• Explore /
  • Poster
  • / Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.

Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.

Abstract Poster

Authors

null

Mashiro Okunaka

Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan

Mashiro Okunaka , Daisuke Kotani , Kazuma Sato , Naoto Fujiwara , Saori Mishima , Kohei Shitara , Takeo Fujita , Takashi Kojima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 271)

DOI

10.1200/JCO.2024.42.3_suppl.271

Abstract #

271

Poster Bd #

C9

Abstract Disclosures

Similar Posters

First Author: Toshiharu Hirose

First Author: Mikako Tamba

First Author: Takako Yoshii

First Author: Satoru Matsuda